LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)
$19.06 -0.21 (-1.0898%)
Analysed LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) News Sources
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Interim US-Iran Deal Lifts Risk Sentiment
18-06-2026
yahoo.com
Legend Biotech (LEGN) Reports a Complete Response in Five of Six Patients at Its Highest Dose
22-06-2026
yahoo.com
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
23-06-2026
yahoo.com
After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching
24-06-2026
247wallst.com
Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress
25-06-2026
yahoo.com
Legend Biotech Announces CEO Transition
27-07-2026
yahoo.com
FDA scientists question Capricor data; Legend CEO steps down
27-07-2026
biopharmadive.com
LEGN Stock Plunges 15% After Sudden CEO Exit — But Analyst Reiterates Optimism In Company’s Under-Development Lymphoma Asset
27-07-2026
stocktwits.com
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
28-07-2026
yahoo.com
Leadership changes afoot at two CGT biotechs
28-07-2026
pharmaceutical-technology.com
What is the current price of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)?
The current price of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) is $19.06.
LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) since the previous trading day is $-0.21.
LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) since the previous trading day is -1.0898%.
What is the most recent average sentiment score for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)?
The most recent average sentiment score for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) is 55 out of 100.
What is the most recent average sentiment for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)?
The most recent sentiment for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) is .
SEC-8K** Filing Available For LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.